Papers
3
Total Citations
174
H-Index
3
About
Dr. Shoji Kubo is a leading figure in hepatobiliary surgery, renowned for pioneering and standardizing minimally invasive approaches to liver resection, particularly for hepatocellular carcinoma (HCC). His primary research focuses on advancing laparoscopic and robot-assisted liver surgery, with a specific emphasis on living donor hepatectomy. Dr. Kubo’s major contributions include co-authoring the landmark "Asia Pacific Consensus Statement on Laparoscopic Liver Resection for Hepatocellular Carcinoma" (94 citations), which established critical guidelines for safety and efficacy in this rapidly evolving field. He also led the "Expert Panel Statement on Laparoscopic Living Donor Hepatectomy" (75 citations), providing essential expert consensus that helped shape the practice of minimally invasive donor surgery. His recent work, "Positioning of Minimally Invasive Liver Surgery for Hepatocellular Carcinoma," further explores the transition from laparoscopic to robot-assisted techniques. Through these highly cited consensus statements and clinical research, Dr. Kubo has profoundly influenced global surgical standards, improving postoperative recovery and outcomes for patients with liver cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2Expert Panel Statement on Laparoscopic Living Donor Hepatectomy75 citations · 2017
- 3